Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH)’s share price passed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $11.42 and traded as high as $12.79. Cipher Pharmaceuticals shares last traded at $12.35, with a volume of 90,126 shares traded.
Cipher Pharmaceuticals Stock Up 4.9 %
The stock’s 50 day moving average price is $11.42 and its 200 day moving average price is $8.17.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Featured Stories
- Five stocks we like better than Cipher Pharmaceuticals
- 5 discounted opportunities for dividend growth investors
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- How to Calculate Stock Profit
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
